Clinical Trials Browser

Phase 2 × Polycythemia Vera × Azacitidine × Clear all

NCT01787487 2025-10-09

Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Phase 2 Active not recruiting

Myeloproliferative Disorders, Polycythemia Vera, Primary Myelofibrosis